Evidence map›Paper›PMID 35899013›Full record

ArticleFrontiers in psychology2022

Cognitive Writing Process Characteristics in Alzheimer's Disease.

Catherine Meulemans, Mariëlle Leijten, Luuk Van Waes, Sebastiaan Engelborghs, Sven De Maeyer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Catherine MeulemansResearch Foundation - Flanders, Brussels, Belgium.
Mariëlle LeijtenDepartment of Management, University of Antwerp, Antwerp, Belgium.
Luuk Van WaesDepartment of Management, University of Antwerp, Antwerp, Belgium.
Sebastiaan EngelborghsDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Sven De MaeyerDepartment of Training and Education Sciences, University of Antwerp, Antwerp, Belgium.
University of Antwerp · BEResearch Foundation - Flanders · BEVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this article, we explore if the observation of writing behavior can assist in the screening and follow-up of mild cognitive impairment (MCI) and mild dementia due to Alzheimer's disease (AD). To this end, we examined the extent to which overall writing process measures and pausing behavior during writing differed between 15 cognitively impaired patients and 15 age- and gender-matched healthy controls. Participants completed two typed picture description tasks that were registered with Inputlog, a keystroke logging program that captures keyboard activity during text production. The following variables were analyzed with mixed-effects models: time on task; number of characters, pauses and Pause-bursts per minute; proportion of pause time; duration of Pause-bursts; and pause time between words. For pause time between words, also the effect of pauses preceding specific word categories was analyzed. Results showed a main effect of group on all variables. In addition, for pause time between words a main effect of part-of-speech was found as well. Results indicate that writing process analysis can possibly serve as a supplementary tool for the screening and follow-up of AD.

Indexed as

Alzheimer’s diseasedementiakeystroke loggingmild cognitive impairmentword categorieswriting processes

Identifiers

PMID35899013
PMCPMC9311409
OpenAlexW4285007550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.